BCDA•benzinga•
DSMB Recommends That Study On Biocardia's CardiALLO-HF Trial Proceeds As Designed Based On 30-day Data Safety Assessment Of Participants Treated In Low Dosage Group
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 15, 2025 by benzinga